Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma

Fig. 3

High HOXB7 expression positively associates with reduced overall survival and disease-free survival rates in HNSCC patients. A, B Overall survival (A) and disease-free survival (B) analyses of HNSCC patients with high or low expression of HOXB7 were estimated by IHC score; IHC, immunohistochemical staining score. C, D Overall survival (C) and diseases-free survival analyses (D) of TCGA-HNSCC patients with high or low expression of HOXB7 mRNA (median value as cutoff) were estimated by Kaplan-Meier method and compared with Log-rank test

Back to article page